205 related articles for article (PubMed ID: 17638192)
21. [Resistance to ganciclovir in cytomegalovirus infection after heart transplant: case report].
Rojas-Contreras C; Cruz-Ku G; Vilcarromero S; Ayllon RV; Valcarcel-Valdivia B
Rev Peru Med Exp Salud Publica; 2018; 35(1):145-149. PubMed ID: 29924261
[TBL] [Abstract][Full Text] [Related]
22. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
[TBL] [Abstract][Full Text] [Related]
23. Ganciclovir/acyclovir prophylaxis reduces the incidence of cytomegalovirus infections in pancreas transplant recipients.
Harland RC; Vernon WB; Bunzendahl H; Thompson JK; Lawrence C; Bollinger RR
Transplant Proc; 1994 Apr; 26(2):432-3. PubMed ID: 8171488
[No Abstract] [Full Text] [Related]
24. Seroconversion and avidity maturation of cytomegalovirus-specific IgG in D+/R- lung transplant patients receiving different prophylactic anti-viral regimens.
Kerschner H; Zweytick B; Klepetko W; Popow-Kraupp T; Puchhammer-Stöckl E
J Heart Lung Transplant; 2012 Jul; 31(7):784-6. PubMed ID: 22516517
[No Abstract] [Full Text] [Related]
25. [Cytomegalovirus infection in lung transplantation; current status, detection, prophylactic treatment].
Aoe M; Tao H; Yamane M; Toyooka S; Sano Y; Okazaki M; Date H
Kyobu Geka; 2007 Oct; 60(11):988-92. PubMed ID: 17926902
[TBL] [Abstract][Full Text] [Related]
26. Emergence of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient.
Bienvenu B; Thervet E; Bedrossian J; Scieux C; Mazeron MC; Thouvenot D; Legendre C
Transplant Proc; 2000 Mar; 32(2):407. PubMed ID: 10715457
[No Abstract] [Full Text] [Related]
27. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
[TBL] [Abstract][Full Text] [Related]
28. Extrapulmonary cytomegalovirus disease in transplant patients.
Petersen EA
Transplant Proc; 1991 Apr; 23(2 Suppl 1):13-6. PubMed ID: 1647557
[No Abstract] [Full Text] [Related]
29. Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?
Singh N; Yu VL
Dig Dis Sci; 1998 Jun; 43(6):1190-2. PubMed ID: 9635606
[No Abstract] [Full Text] [Related]
30. Ganciclovir use during mild renal failure in heart transplantation.
Bastien O; Boulieu R; Bleyzac N; Boissonnat P; Garre JP; Dureau G
Transplant Proc; 1996 Oct; 28(5):2876-7. PubMed ID: 8908106
[No Abstract] [Full Text] [Related]
31. [Human cytomegalovirus infection].
Tanaka-Taya K
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():136-40. PubMed ID: 17455606
[No Abstract] [Full Text] [Related]
32. Ganciclovir for cytomegalovirus: a call for indefinite prophylaxis in lung transplantation.
Valentine VG; Weill D; Gupta MR; Raper B; Laplace SG; Lombard GA; Bonvillain RW; Taylor DE; Dhillon GS
J Heart Lung Transplant; 2008 Aug; 27(8):875-81. PubMed ID: 18656801
[TBL] [Abstract][Full Text] [Related]
33. Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation.
Shapira MY; Resnick IB; Chou S; Neumann AU; Lurain NS; Stamminger T; Caplan O; Saleh N; Efferth T; Marschall M; Wolf DG
Clin Infect Dis; 2008 May; 46(9):1455-7. PubMed ID: 18419454
[TBL] [Abstract][Full Text] [Related]
34. Preemptive and prophylactic ganciclovir therapy for CMV infection in heart transplant patients.
Paniagua MJ; Crespo-Leiro MG; Rodriguez JA; Fojón S; Zúñiga MC; Cañizares A; Rey R; Cuenca JJ; Juffé A; Castro-Beiras A
Transplant Proc; 1999 Sep; 31(6):2528-9. PubMed ID: 10500701
[No Abstract] [Full Text] [Related]
35. Antiviral strategies to combat cytomegalovirus infections in transplant recipients.
Lischka P; Zimmermann H
Curr Opin Pharmacol; 2008 Oct; 8(5):541-8. PubMed ID: 18662804
[TBL] [Abstract][Full Text] [Related]
36. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
[TBL] [Abstract][Full Text] [Related]
37. [Reactivation of cytomegalovirus infection after kidney transplantation in Kaunas University of Medicine Hospital during the period of 2000-2006].
Dalinkeviciene E; Petruliene K; Kuzminskis V; Bumblyte IA; Vaiciūnas K
Medicina (Kaunas); 2007; 43 Suppl 1():121-5. PubMed ID: 17551289
[TBL] [Abstract][Full Text] [Related]
38. Human cytomegalovirus resistance to antiviral drugs: diagnosis, monitoring and clinical impact.
Baldanti F; Gerna G
J Antimicrob Chemother; 2003 Sep; 52(3):324-30. PubMed ID: 12888590
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen.
Thomas LD; Milstone AP; Miller GG; Loyd JE; Stephen Dummer J
Clin Transplant; 2009; 23(4):476-83. PubMed ID: 19453645
[TBL] [Abstract][Full Text] [Related]
40. Ganciclovir-resistant cytomegalovirus.
Legendre C
Lancet; 2000 Oct; 356(9238):1356. PubMed ID: 11073050
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
